Disc Medicine IRON
NASDAQ IRON
$79.49 +0.12 (+0.15%)
As of: Sep 4, 2026 · 3:13 PM EDT

Disc Medicine (IRON) Total Current Liabilities (2020 - 2026)

Disc Medicine (IRON) posted quarterly Total Current Liabilities of $30.4 million for Q2 2026, up 47.34% year-over-year from $20.6 million in Q2 2025, and down 2.51% quarter-over-quarter from $31.1 million in Q1 2026.

Analysis

Disc Medicine (IRON) Total Current Liabilities (2020 - 2026) Analysis & Trends

Disc Medicine (IRON) has reported Total Current Liabilities for 7 consecutive years, with $30.4 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Total Current Liabilities rose 47.34% year-over-year to $30.4 million; the TTM figure through Jun 2026 stood at $30.4 million (up 47.34% YoY), while the FY2025 annual figure was $36.6 million, up 57.15% from the prior year.
  • Total Current Liabilities slipped to $30.4 million in Q2 2026 per IRON's latest filing, from $31.1 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $36.6 million in Q4 2025 and bottomed at $1.5 million in Q3 2022.
  • Historically, Total Current Liabilities has averaged $19.3 million across 5 years, with a median of $20.5 million in 2024.
  • Annual changes were most pronounced in 2022 — Total Current Liabilities tumbled 88.44% — and 2023, when it jumped 884.7%.
  • Disc Medicine's Total Current Liabilities stood at $22.6 million in 2022, then retreated by 5.04% to $21.4 million in 2023, then grew by 8.76% to $23.3 million in 2024, then soared by 57.15% to $36.6 million in 2025, then dropped by 17.14% to $30.4 million in 2026.
  • Business Quant data shows IRON's Total Current Liabilities at $30.4 million in Q2 2026, $31.1 million in Q1 2026, and $36.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 1.58 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 354.06 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 630.93 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 438.74 Mn
10 Disc Medicine 3.08 Bn 3.08 Bn - 30.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.36 Mn
Mar 31, 2026 31.14 Mn
Dec 31, 2025 36.64 Mn
Sep 30, 2025 26.74 Mn
Jun 30, 2025 20.61 Mn
Mar 31, 2025 18.74 Mn
Dec 31, 2024 23.32 Mn
Sep 30, 2024 25.47 Mn
Jun 30, 2024 20.31 Mn
Mar 31, 2024 14.85 Mn
Dec 31, 2023 21.44 Mn
Sep 30, 2023 14.42 Mn
Jun 30, 2023 9.68 Mn
Mar 31, 2023 9.98 Mn
Dec 31, 2022 22.58 Mn
Sep 30, 2022 1.46 Mn
Jun 30, 2022 6.44 Mn
Mar 31, 2022 12.67 Mn
Dec 31, 2021 13.42 Mn
Sep 30, 2021 12.66 Mn